Integrative molecular analyses define correlates of high B7-H3 expression in metastatic castrate-resistant prostate cancer

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2397-768X
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Integrative molecular analyses define correlates of high B7-H3 expression in metastatic castrate-resistant prostate cancer ; volume:6 ; number:1 ; day:2 ; month:11 ; year:2022 ; pages:1-6 ; date:12.2022
npj precision oncology ; 6, Heft 1 (2.11.2022), 1-6, 12.2022

Urheber
Shi, Xiaolei
Day, Abderrahman
Bergom, Hannah E.
Tape, Sydney
Baca, Sylvan C.
Sychev, Zoi E.
Larson, Gabrianne
Bozicevich, Asha
Drake, Justin M.
Zorko, Nicholas
Wang, Jinhua
Ryan, Charles J.
Antonarakis, Emmanuel S.
Hwang, Justin
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1038/s41698-022-00323-2
URN
urn:nbn:de:101:1-2023011721320591664778
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:21 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Shi, Xiaolei
  • Day, Abderrahman
  • Bergom, Hannah E.
  • Tape, Sydney
  • Baca, Sylvan C.
  • Sychev, Zoi E.
  • Larson, Gabrianne
  • Bozicevich, Asha
  • Drake, Justin M.
  • Zorko, Nicholas
  • Wang, Jinhua
  • Ryan, Charles J.
  • Antonarakis, Emmanuel S.
  • Hwang, Justin
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Identification of the receptor B7-H3

Hochschulschrift

Identification of the receptor B7-H3

Pediatric medulloblastoma express immune checkpoint B7-H3

Pediatric medulloblastoma express immune checkpoint B7-H3

Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis

Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis

ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors

ITC-6102RO, a novel B7-H3 antibody-drug conjugate, exhibits potent therapeutic effects against B7-H3 expressing solid tumors

Correction: Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis

Correction: Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis

A promising target for breast cancer: B7-H3

A promising target for breast cancer: B7-H3

B7-H3 is widely expressed in soft tissue sarcomas

B7-H3 is widely expressed in soft tissue sarcomas

Prognostic value of B7-H3 expression in metastatic renal cell carcinoma and its impact on immunotherapy response

Prognostic value of B7-H3 expression in metastatic renal cell carcinoma and its impact on immunotherapy response

The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma

The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma

Clinical significance and correlation of PD-L1, B7-H3, B7-H4, and TILs in pancreatic cancer

Clinical significance and correlation of PD-L1, B7-H3, B7-H4, and TILs in pancreatic cancer

The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma

The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma

Evaluation of the role of B7-H3 haplotype in association with impaired B7-H3 expression and protection against type 1 diabetes in Chinese Han population

Evaluation of the role of B7-H3 haplotype in association with impaired B7-H3 expression and protection against type 1 diabetes in Chinese Han population

Verbundene Objekte